Orchard Therapeutics PLC Stock Ownership - Who owns Orchard Therapeutics?

Insider buying vs selling

Have Orchard Therapeutics PLC insiders been buying or selling?
Frank E. ThomasTitle President Chief Operating Officer2023-03-1020,000$0.46
Frank E. ThomasTitle President Chief Operating Officer2023-02-0920,000$0.46

1 of 1

ORTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORTX insiders and whales buy or sell their stock.

ORTX Shareholders

What type of owners hold Orchard Therapeutics PLC stock?
Glaxosmithkline PLC4.88%12,455,252$64.39MInsider
Ra Capital Management LP3.57%9,111,848$47.11MInsider
Fmr LLC3.21%8,199,080$42.39MInsider
Federated Hermes Inc0.75%1,925,377$9.95MInstitution
Deep Track Capital LP0.46%1,166,670$6.03MInstitution
Chi Advisors LLC0.31%785,738$4.06MInstitution
Temasek Holdings Private Ltd0.17%431,904$2.23MInstitution
Bobby Gaspar0.14%368,158$1.90MInsider
Deerfield Management Company LP Series C0.12%316,169$1.63MInstitution
Citigroup Inc0.07%167,732$867.17kInstitution

1 of 3

ORTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORTX2.20%11.92%Net BuyingNet Buying
MIST62.60%37.40%Net Buying
GRTX43.63%38.93%Net BuyingNet Buying
EPIX72.21%27.79%Net Buying

Orchard Therapeutics Stock Ownership FAQ

Who owns Orchard Therapeutics?

Orchard Therapeutics (NASDAQ: ORTX) is owned by 2.20% institutional shareholders, 11.92% Orchard Therapeutics insiders, and 85.87% retail investors. Glaxosmithkline PLC is the largest individual Orchard Therapeutics shareholder, owning 12.46M shares representing 4.88% of the company. Glaxosmithkline PLC's Orchard Therapeutics shares are currently valued at $64.39M.

If you're new to stock investing, here's how to buy Orchard Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.